MapLight Therapeutics, Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Vishwas Setia's employment with MapLight Therapeutics terminated on June 18, 2026. In exchange for a general release of claims, the Company agreed to pay COBRA health insurance premiums for Setia and eligible dependents through September 30, 2026 (or earlier upon eligibility for new coverage or COBRA expiration). The specific role, compensation details, and severance amount are not disclosed in this release agreement.
Why this rating
Routine executive departure with standard severance/COBRA arrangement. No role title, financial impact quantified, or business-material details disclosed. Immaterial relative to $418.8M asset base.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.